SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Incyte (INCY)
An SI Board Since January 1996
Posts SubjectMarks Bans Symbol
3202 131 0 INCY
Emcee:  scaram(o)uche Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2177Phase IIa Study Results Demonstrate that Once-Daily 200 mg Dosing of INCB9471 Prquidditch-7/24/2007
2176Thanks. Nice to know. And I don't have to work for it.kenhott-5/4/2007
21755/3 cc highlights: (i) 9471 advantages vs. maraviroc - - once daily; without risoftware salesperson-5/3/2007
2174SILVER SPRING, Md., April 24 (Reuters) - A U.S. advisory panel unanimously recomsoftware salesperson-4/24/2007
2173Although it is still burning almost $100M/year. That means there is about 3 yeaX-Ray Man-4/18/2007
2172from annual report, 4/07 CCR5 Antagonists: Mechanism of Action Human immunodesoftware salesperson-4/18/2007
2171Cramer says INCY is sitting on $300M in cash - thats alot of dough. Kentrkf-4/10/2007
2170Cramer recommends INCY: thestreet.comD.Lu-4/10/2007
2169Now regarding the Finances: 2006 Financial Results Cash Position As of Decembdr.praveen-2/15/2007
2168Paul A. Friedman, Incyte's President and Chief Executive Officer stated, &qudr.praveen-2/15/2007
2167We have a secret CCR5 here :-)with once daily convenient dosing and without ritodr.praveen-2/8/2007
2166FDA Panel to Review Pfizer HIV Drug Thursday February 8, 1:51 pm ET By Matthew software salesperson-2/8/2007
2165INCB7839 (Sheddase inhibitor)Cancer Phase I/II dose-ranging study in refractory dr.praveen-1/10/2007
2164"I agree that the 11b-HSD inhibitor results are impressive" I once cadr.praveen-1/10/2007
2163Hello SS- Yep, I am somewhat familiar to the JAK inhibitor programs that are onBiotech Jim-1/10/2007
2162Must have impressed a lot of people. New 52 week high on over 2 million shares. Steve Lokness-1/9/2007
2161JPM update 1/8/07 Incy pipeline 1/07: 1) sheddase inhibitor - - incb7839; solsoftware salesperson-1/9/2007
2160There are enough people following it today to account for a >1mm share day.tom pope-1/8/2007
2159INCY upgrade by Piper Jaffray and news release biz.yahoo.com The Piper press Steve Lokness-1/8/2007
2158It seems to me that Pfizer's problems with its other drugs could make their Charles Tutt-12/4/2006
2157updates in <B> bold </B> based on 11/2/06 cc: Incy pipeline <B&gsoftware salesperson-11/2/2006
2156Will INCY ever make any money?! I owned this one in the late 90s. Its "genehoyasaxa-9/21/2006
2155This roll-out of the convertible debt due in a few months was prudent and neededtuck-9/21/2006
2154Hey, there you are! Thanks & Best to You! Cheers, Tucktuck-7/27/2006
2153updates in bold: Incy pipeline <B> 7</B>/06: 1) sheddase inhibitorsoftware salesperson-7/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News